Enterprise Women’s Fertility Platforms sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Enterprise Women’s Fertility Platforms
1.1 - About Enterprise Women’s Fertility Platforms sector
Enterprise Women’s Fertility Platforms deliver digital tools that help consumers and care teams plan, monitor, and manage reproductive health. Vendors combine cycle tracking, ovulation prediction, virtual care, and diagnostics to guide conception and treatment decisions. By unifying patient data across apps, wearables, and clinics, they enable more personalized fertility journeys, streamline access to specialists, and improve visibility into outcomes for providers, payers, and employer benefit programs.
Offerings typically include cycle-tracking apps with machine-learning ovulation prediction, integration with at-home hormone assays and basal temperature wearables, and telehealth workflows for consults, prescriptions, and follow-up. For clinics, vendors provide IVF care pathway management, appointment scheduling, lab result exchange, and EHR integration to synchronize data. Many platforms add patient education, community support, and cohort analytics to monitor adherence, predict success rates, and optimize protocols across populations and individual cases.
Primary buyers include fertility clinics and IVF centers, OB/GYN and reproductive endocrinology practices, and employer benefit programs and payers offering fertility support. These platforms help boost patient acquisition and retention, shorten time-to-treatment with streamlined intake and scheduling, improve pregnancy success rates through data-informed protocols, and reduce administrative overhead via integrated labs, billing, and EHR connectivity, creating measurable operational and clinical performance improvements.
2. Buyers in the Enterprise Women’s Fertility Platforms sector
2.1 Top strategic acquirers of Enterprise Women’s Fertility Platforms companies
Legacy
- Description: Provider of at-home male fertility services offering mail-in sperm testing kits, secure sperm freezing, DNA fragmentation analysis and educational resources, making sperm health assessment and preservation affordable and accessible through partnerships with health plans, military programs and employers.
- Key Products:
- Standard Semen Analysis Kit: At-home kit with sterile cup and transport liquid enabling clinic-grade measurement of volume, concentration, motility, morphology and post-thaw viability, with 48-hour dashboard results and expert consults
- For Tomorrow Bundle: Two semen analysis kits
- STI test, and five-year multi-location cryostorage for eight sperm vials, providing fertility preservation and convenient future use for IVF
- IUI, or deployment
- Forever Package: Three semen analyses
- DNA fragmentation analysis
- STI test, and lifetime cryostorage, securing long-term reproductive options for those undergoing hormone therapy, cancer treatment, or vasectomy
- Sperm Freezing Service: Multi-geography, multi-tank storage in CLIA-registered labs, splitting vials across two facilities for risk-free preservation with renewable storage terms and real-time dashboard vial tracking.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Enterprise Women’s Fertility Platforms sector
M&A buyer group 1: FemTech
Advantia Health
- Type: N/A
- Employees: ●●●●●
- Description: Provider of specialized women’s and individual healthcare services, Advantia Health delivers personalized specialty care—including pelvic floor health, hormone therapy, laparoscopic surgery, telehealth, and LGBTQ+ affirmative treatments—through a network of clinics and virtual consultations.
- Key Products:
- Bladder Leakage & Incontinence Care: Provides advanced diagnostics and treatment plans targeting urinary incontinence, leveraging specialized expertise to improve bladder function and patient quality of life
- Laparoscopic Surgery: Delivers minimally invasive surgical interventions for select gynecologic conditions, utilizing small incisions to reduce postoperative pain, expedite recovery, and minimize hospital stays
- LGBTQ+ and Gender Affirming Care: Designs personalized, gender-affirming treatment pathways, hormonal support, and ongoing health monitoring to meet unique needs of LGBTQ+ individuals in an inclusive environment
- Telehealth Visits: Enables virtual consultations and follow-ups through secure digital channels, granting convenient access to specialists regardless of patient location, mobility constraints, or scheduling challenges.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Enterprise Women’s Fertility Platforms sector
3.1 - Buyout funds in the Enterprise Women’s Fertility Platforms sector
2.2 - Strategic buyer groups for Enterprise Women’s Fertility Platforms sector
4 - Top valuation comps for Enterprise Women’s Fertility Platforms companies
4.2 - Public trading comparable groups for Enterprise Women’s Fertility Platforms sector
Valuation benchmark group 1: Population Health Management Software Companies
Privia Health
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of technology-driven healthcare solutions, optimizing physician practices, enhancing patient experiences, and rewarding doctors for high-value care through collaboration with medical groups, health plans, and health systems.
- Key Products:
- Practice Management: Tools and services to optimize physician practices
- Patient Portal: Platform for patient engagement and communication
- Value-Based Care: Strategies to improve care quality and reduce costs
- Virtual Care: Telehealth services for remote patient consultations
- Fitness and Nutrition Plans: Personalized health assessments and plans for patients